 <h1>Tranylcypromine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to tranylcypromine: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors. Tranylcypromine sulfate is not approved for use in pediatric patients.Excessive consumption of foods or beverages with significant tyramine content or the use of certain drugs with tranylcypromine sulfate or after tranylcypromine sulfate discontinuation can precipitate hypertensive crisis. Monitor blood pressure and allow for medication-free intervals between administration of tranylcypromine sulfate and interacting drugs. Instruct patients to avoid ingestion of foods and beverages with high tyramine content.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, tranylcypromine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking tranylcypromine:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Absence of or decrease in body movement</li>
<li>actions that are out of control</li>
<li>agitation</li>
<li>anxiety</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>chest pain</li>
<li>chills</li>
<li>confusion</li>
<li>confusion about identity, place, and time</li>
<li>cough</li>
<li>dark urine</li>
<li>decrease in frequency of urination</li>
<li>decrease in urine volume</li>
<li>decreased awareness or responsiveness</li>
<li>depression</li>
<li>difficulty in passing urine (dribbling)</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>fever with or without chills</li>
<li>general feeling of tiredness or weakness</li>
<li>headache</li>
<li>hoarseness</li>
<li>hostility</li>
<li>hyperventilation</li>
<li>increased need to urinate</li>
<li>irritability</li>
<li>light-colored stools</li>
<li>longer than usual time to ejaculation of semen</li>
<li>loss of bladder control</li>
<li>loss of consciousness</li>
<li>lower back or side pain</li>
<li>muscle twitching</li>
<li>nausea</li>
<li>nervousness</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>passing urine more often</li>
<li>pinpoint red spots on the skin</li>
<li>rapid weight gain</li>
<li>restlessness</li>
<li>seizures</li>
<li>severe sleepiness</li>
<li>shakiness and unsteady walk</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>sudden jerky movements of the body</li>
<li>swelling of the face, ankles, or hands</li>
<li>swollen glands</li>
<li>talking, feeling, and acting with excitement</li>
<li>trouble with sleeping</li>
<li>troubled breathing with exertion</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
<li>unusual bleeding or bruising</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness</li>
<li>upper right abdominal pain</li>
<li>vomiting</li>
<li>yellow eyes and skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of tranylcypromine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Blurred vision</li>
<li>constipation</li>
<li>continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>decreased interest in sexual intercourse</li>
<li>diarrhea</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>hair loss or thinning of the hair</li>
<li>hearing loss</li>
<li>hives or welts, itching, skin rash</li>
<li>inability to have or keep an erection</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>loss of appetite</li>
<li>memory loss</li>
<li>muscle spasm</li>
<li>redness of the skin</li>
<li>stomach pain</li>
<li>unable to sleep</li>
<li>weakness</li>
<li>weight loss</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tranylcypromine: oral tablet</i></p><h3>General</h3><p>The most important adverse event is hypertensive crisis, which may be fatal.  The most common adverse event is insomnia, which can frequently be overcome by giving the last dose of the day no later than 3 pm or reducing dosage.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Severe hypertensive reactions have occurred, notably with tyramine containing foods, and are sometimes fatal.  Symptoms may include pain and stiffness in the neck, multiple extrasystoles, often with substernal pain, sweating and pallor, sometimes followed by flushing, mydriasis, and photophobia.</p>
<p></p>
<p>Hypotension and postural hypotension were usually temporary, but sometimes required discontinuation of treatment.  Blood pressure rapidly returned to pretreatment levels once treatment was stopped.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Edema, flushing, hypertension, hypertensive crisis, hypotension, multiple extrasystoles, pallor, palpitation, postural hypotension/postural hypotension with syncope, severe hypertensive reaction, substernal pain, tachycardia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Adverse effects on the ability to drive and operate machinery, akathisia, drowsiness, dizziness, dysgeusia, headache, headache without blood pressure elevation, hyperreflexia, lethargy, myoclonic jerks, numbness, nystagmus, paresthesia, sedation, seizures, serotonin syndrome, syncope, throbbing headache, tremor, unusually frequent headaches</p>
<p><b>Postmarketing reports</b>: Akinesia, ataxia, memory loss<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Aggravation of coexisting symptoms of depression, agitation, anxiety, discontinuation syndrome, drug dependence, excessive stimulation, hallucinations, hypomania, insomnia, loss of libido, mania, manic symptoms, overexcitement, overstimulation, restlessness, sleep disturbances, suicidal behavior, suicidal ideation/thoughts, withdrawal symptoms</p>
<p><b>Postmarketing reports</b>: Confusion, disorientation<sup>[Ref]</sup></p><p>Drug dependence with tolerance to high doses may occur in patients without a history of drug dependence.</p>
<p></p>
<p>Overstimulation included increased anxiety, agitation, and manic symptoms, and was usually a sign of excessive therapeutic action.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Abdominal pain, constipation, diarrhea, dry mouth, nausea, vomiting</p>
<p><b>Postmarketing reports</b>: Fissuring in corner of mouth<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Syndrome of inappropriate antidiuretic syndrome (SIADH)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Delayed ejaculation, impotence, retarded ejaculation, urinary retention</p>
<p><b>Postmarketing reports</b>: Urinary frequency, urinary incontinence<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Agranulocytosis, anemia, blood dyscrasias, leukopenia, thrombocytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Elevated aminotransferases, hepatitis, hepatocellular damage, hepatotoxicity, jaundice<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Muscle spasm, neck stiffness</p>
<p><b>Postmarketing reports</b>: Localized scleroderma<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Chills, drug tolerance, excessive therapeutic action, fatigue, pain, persistence of MAO inhibition after discontinuation, tinnitus, weakness<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, mydriasis, photophobia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Alopecia, skin rash/rash, sweating</p>
<p><b>Postmarketing reports</b>: Flare up of cystic acne, urticaria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Hypoglycemia, impaired water excretion, significant anorexia, weight gain<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Parnate (tranylcypromine)." SmithKline Beecham, Philadelphia, PA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What are some common side effects of antidepressants?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about tranylcypromine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>98 Reviews</li>
<li>Drug class: monoamine oxidase inhibitors</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tranylcypromine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Parnate</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Depression</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tranylcypromine: oral tablet</i></p><h3>General</h3><p>The most important adverse event is hypertensive crisis, which may be fatal.  The most common adverse event is insomnia, which can frequently be overcome by giving the last dose of the day no later than 3 pm or reducing dosage.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Severe hypertensive reactions have occurred, notably with tyramine containing foods, and are sometimes fatal.  Symptoms may include pain and stiffness in the neck, multiple extrasystoles, often with substernal pain, sweating and pallor, sometimes followed by flushing, mydriasis, and photophobia.</p><p></p><p>Hypotension and postural hypotension were usually temporary, but sometimes required discontinuation of treatment.  Blood pressure rapidly returned to pretreatment levels once treatment was stopped.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Edema, flushing, hypertension, hypertensive crisis, hypotension, multiple extrasystoles, pallor, palpitation, postural hypotension/postural hypotension with syncope, severe hypertensive reaction, substernal pain, tachycardia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Adverse effects on the ability to drive and operate machinery, akathisia, drowsiness, dizziness, dysgeusia, headache, headache without blood pressure elevation, hyperreflexia, lethargy, myoclonic jerks, numbness, nystagmus, paresthesia, sedation, seizures, serotonin syndrome, syncope, throbbing headache, tremor, unusually frequent headaches</p><p><b>Postmarketing reports</b>: Akinesia, ataxia, memory loss<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Aggravation of coexisting symptoms of depression, agitation, anxiety, discontinuation syndrome, drug dependence, excessive stimulation, hallucinations, hypomania, insomnia, loss of libido, mania, manic symptoms, overexcitement, overstimulation, restlessness, sleep disturbances, suicidal behavior, suicidal ideation/thoughts, withdrawal symptoms</p><p><b>Postmarketing reports</b>: Confusion, disorientation<sup>[Ref]</sup></p><p>Drug dependence with tolerance to high doses may occur in patients without a history of drug dependence.</p><p></p><p>Overstimulation included increased anxiety, agitation, and manic symptoms, and was usually a sign of excessive therapeutic action.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Abdominal pain, constipation, diarrhea, dry mouth, nausea, vomiting</p><p><b>Postmarketing reports</b>: Fissuring in corner of mouth<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Syndrome of inappropriate antidiuretic syndrome (SIADH)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Delayed ejaculation, impotence, retarded ejaculation, urinary retention</p><p><b>Postmarketing reports</b>: Urinary frequency, urinary incontinence<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Agranulocytosis, anemia, blood dyscrasias, leukopenia, thrombocytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Elevated aminotransferases, hepatitis, hepatocellular damage, hepatotoxicity, jaundice<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Muscle spasm, neck stiffness</p><p><b>Postmarketing reports</b>: Localized scleroderma<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Chills, drug tolerance, excessive therapeutic action, fatigue, pain, persistence of MAO inhibition after discontinuation, tinnitus, weakness<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, mydriasis, photophobia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Alopecia, skin rash/rash, sweating</p><p><b>Postmarketing reports</b>: Flare up of cystic acne, urticaria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Hypoglycemia, impaired water excretion, significant anorexia, weight gain<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Parnate (tranylcypromine)." SmithKline Beecham, Philadelphia, PA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What are some common side effects of antidepressants?</li>
</ul><h2>More about tranylcypromine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>98 Reviews</li>
<li>Drug class: monoamine oxidase inhibitors</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tranylcypromine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Depression</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>